Adhera Therapeutics, Inc.
ATRX
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.54M | 271.00K | -886.00K | -335.00K | -1.80M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 245.80K | 392.00K | 608.00K | 544.00K | 777.40K |
| Total Other Non-Cash Items | 1.97M | -958.00K | -75.00K | -570.00K | -510.20K |
| Change in Net Operating Assets | 1.29M | -21.00K | 43.00K | 208.00K | 870.60K |
| Cash from Operations | -29.20K | -316.00K | -310.00K | -153.00K | -666.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -16.10K | 305.00K | 500.00K | 100.00K | 0.00 |
| Total Debt Repaid | 4.20K | 0.00 | -95.00K | -30.00K | -50.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.70K | 0.00 | -58.00K | -18.00K | 200.00 |
| Cash from Financing | 3.80K | 305.00K | 347.00K | 52.00K | -49.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.40K | -11.00K | 37.00K | -101.00K | -715.70K |
